MRXD Stock Overview
Provides and markets eyewear products in Germany and internationally. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Mister Spex SE Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €5.00 |
52 Week High | €9.98 |
52 Week Low | €3.58 |
Beta | 0 |
11 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -56.67% |
Recent News & Updates
Recent updates
Shareholder Returns
MRXD | GB Specialty Retail | GB Market | |
---|---|---|---|
7D | 0% | -0.8% | 0.7% |
1Y | n/a | -5.5% | 6.1% |
Return vs Industry: Insufficient data to determine how MRXD performed against the UK Specialty Retail industry.
Return vs Market: Insufficient data to determine how MRXD performed against the UK Market.
Price Volatility
MRXD volatility | |
---|---|
MRXD Average Weekly Movement | n/a |
Specialty Retail Industry Average Movement | 4.5% |
Market Average Movement | 4.7% |
10% most volatile stocks in GB Market | 10.4% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: MRXD has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MRXD's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2007 | 1,350 | Dirk Graber | corporate.misterspex.com |
Mister Spex SE provides eyewear products in Germany, Austria, Finland, France, the Netherlands, Norway, Spain, Sweden, Switzerland, and the United Kingdom. It offers various types of prescription glasses, sunglasses, and contact lenses. The company offers its products under the independent labels, private labels, and various premium and luxury brands through online shops and retail stores, as well as a network of partner opticians.
Mister Spex SE Fundamentals Summary
MRXD fundamental statistics | |
---|---|
Market cap | €132.31m |
Earnings (TTM) | -€31.79m |
Revenue (TTM) | €217.86m |
0.6x
P/S Ratio-4.2x
P/E RatioIs MRXD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MRXD income statement (TTM) | |
---|---|
Revenue | €217.86m |
Cost of Revenue | €163.32m |
Gross Profit | €54.54m |
Other Expenses | €86.34m |
Earnings | -€31.79m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -0.96 |
Gross Margin | 25.04% |
Net Profit Margin | -14.59% |
Debt/Equity Ratio | 2.0% |
How did MRXD perform over the long term?
See historical performance and comparison